wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26744088-4025A084-060D-4B48-AD6E-60C84489073F
Q26744088-4025A084-060D-4B48-AD6E-60C84489073F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26744088-4025A084-060D-4B48-AD6E-60C84489073F
Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
P2860
Q26744088-4025A084-060D-4B48-AD6E-60C84489073F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26744088-4025A084-060D-4B48-AD6E-60C84489073F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7fd541eb20275513e0e59227025749d27419685e
P2860
A phase I dose escalation study with anti-CD44v6 bivatuzumab mertansine in patients with incurable squamous cell carcinoma of the head and neck or esophagus